13Feb/19
The World’s First Nanobody Drug! Sanofi Cablivi is Approved by FDA for the Treatment of Rare Thrombotic Diseases
French pharmaceutical giant Sanofi recently announced that the US Food and Drug Administration (FDA) has approved the nanobody drug Cablivi (caplacizumab), combined with plasma exchange and immunosuppressive therapy. For the treatment ofRead More…